An exciting area in drug development, immunotherapy is being increasingly utilized by patients with different cancer types. These treatments...
Monday ushered in a ray of hope and promise for the lung cancer community at the AACR Annual Meeting...
The U.S. Food and Drug Administration (FDA) recently approved expanding the use of the immunotherapeutic durvalumab (Imfinzi) to include...
Last week, the U.S. Food and Drug Administration (FDA) approved the antihormone agent apalutamide (Erleada) for treating men with...
The field of medical oncology is undergoing a remarkable transformation. Cancers that were once considered death sentences, such as...
Early detection of cancer is arguably a holy grail in the field of cancer research. Catching the disease at...
The U.S. Food and Drug Administration (FDA) recently added a new therapeutic to the armamentarium for oncologists treating patients...
In honor of International Day of Women and Girls in Science, a United Nations initiative aimed at narrowing a...
On Friday, the U.S. Food and Drug Administration (FDA) approved the molecularly targeted therapeutic olaparib (Lynparza) for treating certain...
A little-talked-about provision of the 2010 Patient Protection and Affordable Care Act designed to improve access to innovative medical...